Sofosbuvir + Ribavirin Cures Many with Hepatitis C in Phase II Clinical Trial
Hepatitis C Cure? Sofosbuvir Plus Ribavirin Eliminate Liver Infection In Promising NIH Trial
By Nsikan Akpan | Aug 27, 2013
Hepatitis C patients who don’t normally respond to standard treatment may have a new weapon for fighting their viral liver disease. A combination drug program, with sofosbuvir and ribavirin, has cured a majority of volunteers in a Phase II clinical trial conducted by the National Institute of Allergy and Infectious Disease (NIAID), a branch of the National Institutes of Health (NIH).
Continue reading this entire article: